A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)940-948
JournalBritish Journal of Cancer
Volume115
Issue number8
DOIs
Publication statusPublished - 11 Oct 2016

Cite this

@article{efd68579814849609dc379816f0c4326,
title = "A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer",
keywords = "bioassay, VEGF, bevacizumab, proliferation assay, angiogenesis, antibody",
author = "Wentink, {Madelon Q.} and Broxterman, {Henk J.} and Lam, {Siu W.} and Epie Boven and Maudy Walraven and Griffioen, {Arjan W.} and Roberto Pili and {van der Vliet}, {Hans J.} and {de Gruijl}, {Tanja D.} and Verheul, {Henk M. W.}",
year = "2016",
month = "10",
day = "11",
doi = "10.1038/bjc.2016.275",
language = "English",
volume = "115",
pages = "940--948",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer

AU - Wentink, Madelon Q.

AU - Broxterman, Henk J.

AU - Lam, Siu W.

AU - Boven, Epie

AU - Walraven, Maudy

AU - Griffioen, Arjan W.

AU - Pili, Roberto

AU - van der Vliet, Hans J.

AU - de Gruijl, Tanja D.

AU - Verheul, Henk M. W.

PY - 2016/10/11

Y1 - 2016/10/11

KW - bioassay

KW - VEGF

KW - bevacizumab

KW - proliferation assay

KW - angiogenesis

KW - antibody

U2 - 10.1038/bjc.2016.275

DO - 10.1038/bjc.2016.275

M3 - Article

VL - 115

SP - 940

EP - 948

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 8

ER -